Natural source, bioactivity and synthesis of benzofuran derivatives

Y Miao, Y Hu, J Yang, T Liu, J Sun, X Wang - RSC advances, 2019 - pubs.rsc.org
Benzofuran compounds are a class of compounds that are ubiquitous in nature. Numerous
studies have shown that most benzofuran compounds have strong biological activities such …

Metal-catalyzed reactions of organic nitriles and boronic acids to access diverse functionality

HN Dhara, A Rakshit, T Alam, BK Patel - Organic & Biomolecular …, 2022 - pubs.rsc.org
The nitrile or cyano (–CN) group is one of the most appreciated and effective functional
groups in organic synthesis, having a polar unsaturated C–N triple bond. Despite sufficient …

Palladium-Catalyzed Denitrative α-Arylation of Heteroarenes with Nitroarenes via C–H and C–NO2 Bond Activations

J Yao, Y Xiao, H Li, X Yang, J Du, Y Yin, L Feng… - Organic …, 2024 - ACS Publications
A general approach for the α-arylation of heteroarenes with nitroarenes via denitrative
coupling is reported for the first time. Various heteroarenes, including derivatives of furan …

Binding to amyloid‐β protein by photothermal blood‐brain barrier‐penetrating nanoparticles for inhibition and disaggregation of fibrillation

H Geng, Y Pan, R Zhang, D Gao… - Advanced Functional …, 2021 - Wiley Online Library
Excess accumulation of amyloid‐β (Aβ) protein in the brain is the primary pathogenesis of
Alzheimer's disease (AD). Inhibition of Aβ fibrillation and disaggregation of Aβ fibrils is an …

N-Benzyl Benzamide Derivatives as Selective Sub-Nanomolar Butyrylcholinesterase Inhibitors for Possible Treatment in Advanced Alzheimer's Disease

C Du, L Wang, Q Guan, H Yang, T Chen… - Journal of Medicinal …, 2022 - ACS Publications
Herein, we report a series of selective sub-nanomolar inhibitors against
butyrylcholinesterase (BChE). These compounds, bearing a novel N-benzyl benzamide …

Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds

W Qiu, H Liu, Y Liu, X Lu, L Wang, Y Hu… - Medicinal Research …, 2023 - Wiley Online Library
Alzheimer's disease (AD) is a progressive neurodegenerative disease that is difficult to treat.
Extracellular amyloid is the principal pathological criterion for the diagnosis of AD. Amyloid β …

Probing 2-acetylbenzofuran hydrazones and their metal complexes as α-glucosidase inhibitors

S Khan, M Tariq, M Ashraf, S Abdullah… - Bioorganic …, 2020 - Elsevier
Inhibition of α-glucosidase is one of the important approaches in designing antidiabetic
drugs for its role in decrease of the carbohydrates digestion to avoid post-prandial increase …

An update on benzofuran inhibitors: a patent review

KM Dawood - Expert Opinion on Therapeutic Patents, 2019 - Taylor & Francis
Introduction: Benzofuran is a fundamental unit in numerous bioactive heterocycles. They
have attracted chemists and medical researchers due to their broad range of biological …

An efficient synthesis, structural (SC-XRD) and spectroscopic (FTIR, 1HNMR, MS spectroscopic) characterization of novel benzofuran-based hydrazones: An …

M Khalid, MN Arshad, MN Tahir, AM Asiri… - Journal of Molecular …, 2020 - Elsevier
Herein, the benzofuran-based hydrazones derivatives such as N'-(1-(benzofuran-2-yl)
ethylidene) isonicotinohydrazide (BEINH), N'-(1-(benzofuran-2-yl) ethylidene) nicotine …

Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for In Vivo Theranostics of Alzheimer's Disease

L Wang, T Sun, T Zhen, W Li, H Yang… - Journal of Medicinal …, 2024 - ACS Publications
Butyrylcholinesterase (BChE) is a promising biomarker and effective therapeutic target for
Alzheimer's disease (AD). Herein, we designed a BChE-activated near-infrared (NIR) probe …